The global Softgel Capsules Market is witnessing steady growth driven by increasing consumer demand for easy-to-swallow, high-bioavailability oral dosage forms. Softgel capsules, known for their smooth texture and enhanced absorption, are used to encapsulate liquid or semi-solid ingredients such as vitamins, essential oils, and pharmaceuticals. Their aesthetic appeal, convenience, and ability to mask unpleasant tastes make them a preferred choice across dietary supplements and pharmaceutical applications.
The market is expanding due to the rise in nutraceutical consumption, growing geriatric populations, and advancements in encapsulation technology. Pharmaceutical companies increasingly rely on softgel formats for drugs that require improved bioavailability and controlled release. Furthermore, the shift toward preventive healthcare and personalized nutrition continues to boost softgel capsule adoption globally.
A major growth driver for the Softgel Capsules Market is the rising demand for nutraceutical and dietary supplements. Consumers are increasingly adopting supplements containing omega-3 fatty acids, vitamins, and minerals to enhance immunity and overall health. Softgel capsules provide superior stability and ease of consumption compared to tablets or powders, making them highly attractive. Moreover, the pharmaceutical sector’s push toward patient-centric formulations further propels market expansion.
The increasing adoption of plant-based and vegan capsule formulations presents a significant market opportunity. As consumer preferences shift toward clean-label, non-animal-derived ingredients, manufacturers are investing in innovative non-gelatin capsules made from plant polymers such as starch and hydroxypropyl methylcellulose (HPMC). This trend aligns with the global surge in veganism and sustainability-conscious product development, creating lucrative opportunities for market players.
Softgel Capsules Market, Segmentation
The Softgel Capsules Market is segmented on the basis of Type, Application, and End-User.
Type
- The Type segment is further classified into Gelatin-based Softgel Capsules and Non-Gelatin/Vegetarian Softgel Capsules. Among these, the Gelatin-based Softgel Capsules sub-segment accounted for the highest market share in 2024. This dominance is attributed to their wide availability, lower production cost, and superior encapsulation capabilities for both hydrophilic and lipophilic ingredients. Despite increasing demand for plant-based alternatives, gelatin capsules remain the preferred choice in pharmaceuticals due to their proven performance and regulatory acceptance.
Application
- The Application segment is further classified into Pharmaceuticals, Nutraceuticals, and Cosmetics & Personal Care. Among these, the Nutraceuticals sub-segment accounted for the highest market share in 2024. This growth is fueled by rising consumer focus on preventive health and the increasing use of softgel capsules to deliver vitamins, minerals, and herbal extracts effectively. The segment benefits from growing online supplement sales and global awareness of nutrition-driven wellness.
Some of The Leading/Active Market Players Are
• Catalent Inc. (U.S.)
• Aenova Group (Germany)
• Sirio Pharma Co., Ltd. (China)
• Capsugel (U.S.)
• EuroCaps Ltd. (U.K.)
• Thermo Fisher Scientific Inc. (U.S.)
• BASF SE (Germany)
• Lonza Group AG (Switzerland)
• Robinson Pharma Inc. (U.S.)
• Fuji Capsule Co., Ltd. (Japan)
• Soft Gel Technologies Inc. (U.S.)
• Nature’s Bounty Co. (U.S.)
• Amway Corp. (U.S.)
• CapsCanada (Canada)
• ACG Worldwide (India)
and other active players.
Key Industry Developments
- In June 2024, Catalent Inc. announced the expansion of its softgel capsule manufacturing facility in Kansas City, U.S., to enhance capacity for nutraceutical and pharmaceutical clients. This investment strengthens Catalent’s position in the North American market and supports the growing demand for customized softgel formulations with rapid turnaround times.
- In March 2025, Sirio Pharma introduced a new line of plant-based softgel capsules designed for vegan consumers seeking clean-label supplements. The innovation aligns with global sustainability goals, offering eco-friendly alternatives without compromising product quality or stability.
Key Findings of the Study
• Gelatin-based softgels dominated the market in 2024.
• Nutraceuticals emerged as the leading application segment.
• North America held the largest regional market share.
• Growing preference for vegan and plant-based softgels drives innovation.
• Expansion of nutraceutical and pharmaceutical production capacities fuels growth.
